Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 589 clinical trials
featured
Pediatric Hyperparathyroidism & Chronic Kidney Disease

Children with Secondary Hyperparathyroidism & Chronic Kidney Disease are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.  

  • 57 views
  • 18 Jan, 2019
  • 1 location
featured
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis

This is a randomized, open label, parallel, active comparator study in patients aged 5– 18 years with Chronic Kidney Disease (CKD) Stages 3 and 4 and secondary hyperparathyroidism (SHPT) not

  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
Improving Rental Outcomes Collaborative (IROC) to Improve Health, Longevity and Quality of Life for Children with Kindey Disease

including chronic kidney disease (CKD), dialysis and transplant.  

  • 25 views
  • 11 Jun, 2020
  • 1 location
featured
Heart Failure with Chronic Kidney Disease - The MIRACLE Study

are seeking volunteers with HF and CKD to evaluate a trial medication that may help.

  • 0 views
  • 08 Mar, 2021
  • 1 location
featured
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION

CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE

  • 358 views
  • 25 Mar, 2021
  • 1 location
featured
AKB-6548-CI-0014 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE CORRECTION OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE MAINTENANCE TREATMENT OF ANEMIA IN SUBJECTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT- CONVERSION

CHRONIC KIDNEY DISEASE (NDD-CKD) (PRO2TECT - CORRECTION) AND AKB-6548-CI-0015 PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ORAL VADADUSTAT FOR THE

  • 252 views
  • 25 Mar, 2021
  • 1 location
featured
Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

  • 466 views
  • 25 Mar, 2021
  • 1 location
featured
Kidney Disease in Type 2 Diabetics

Kidney Disease in Type 2 Diabetics

  • 1306 views
  • 25 Mar, 2021
  • 1 location
featured
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

  • 102 views
  • 08 Nov, 2020
  • 1 location
featured
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

  • 552 views
  • 25 Mar, 2021
  • 1 location